Literature DB >> 20803700

Mucosal healing as an index of colitis activity: back to histological healing for future indices.

Burton I Korelitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20803700     DOI： 10.1002/ibd.21268

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  9 in total

Review 1.  Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.

Authors:  Weiwei Jiang; Xuhang Li
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

2.  Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.

Authors:  Burton I Korelitz
Journal:  Dig Dis Sci       Date:  2017-02       Impact factor: 3.199

Review 3.  Mucosal healing and deep remission: what does it mean?

Authors:  Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

4.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

5.  Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Authors:  Bing Zhang; Alakh Gulati; Omeed Alipour; Ling Shao
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 9.071

Review 6.  Emerging concepts in non-invasive monitoring of Crohn's disease.

Authors:  Wojciech Marlicz; Karolina Skonieczna-Żydecka; Konstantinos John Dabos; Igor Łoniewski; Anastasios Koulaouzidis
Journal:  Therap Adv Gastroenterol       Date:  2018-04-18       Impact factor: 4.409

7.  Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.

Authors:  Aaron Yarlas; Geert D'Haens; Mary Kaye Willian; Megan Teynor
Journal:  Inflamm Bowel Dis       Date:  2018-01-18       Impact factor: 5.325

8.  Transcriptional Signatures That Define Ulcerative Colitis in Remission.

Authors:  Christopher G Fenton; Hagar Taman; Jon Florholmen; Sveinung W Sørbye; Ruth H Paulssen
Journal:  Inflamm Bowel Dis       Date:  2021-01-01       Impact factor: 5.325

Review 9.  Colonoscopic evaluation in ulcerative colitis.

Authors:  Elizabeth R Paine
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-05-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.